Neuropace
NPCE
80 hedge funds and large institutions have $268M invested in Neuropace in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 28 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
9.81% more ownership
Funds ownership: 68.62% → 78.43% (+9.8%)
7% more capital invested
Capital invested by funds: $251M → $268M (+$16.8M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less call options, than puts
Call options by funds: $209K | Put options by funds: $226K
18% less funds holding
Funds holding: 98 → 80 (-18)
64% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$29.2M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.08M |
| 3 |
AC
Armistice Capital
New York
|
+$1.37M |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.35M |
| 5 |
Goldman Sachs
New York
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$5.57M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.46M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.07M |
| 4 |
Two Sigma Investments
New York
|
-$654K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$621K |
NPCE Hedge Fund Activity: Q3 2025 in Review
80 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q3 2025, worth a combined $268M — up 6.7% from $251M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of NPCE and 10 opened new positions — a net loss of 18 holders — while 21 trimmed existing stakes and 33 added.
The largest buyer was Polar Capital Holdings, opening a new position worth an estimated $29.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.57M sold.
- 80 institutional investors held Neuropace (NPCE) as of Q3 2025, down from 98 in Q2 2025.
- Funds reported $268M of Neuropace stock for Q3 2025, up 6.7% quarter-over-quarter.
- 10 funds opened new Neuropace positions in Q3 2025 and 28 closed out, a net change of -18 holders.
- The largest Neuropace buyer in Q3 2025 was Polar Capital Holdings, an estimated $29.2M added.
- The largest Neuropace seller in Q3 2025 was Deerfield Management, an estimated $5.57M sold.
Based on aggregated 13F filings for Q3 2025.